Brainomix
PrivateLast Round
Series C
Extension
Feb 24, 2026
Total Funding Raised
$69.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Brainomix is a medical technology company that provides an AI-powered platform with imaging biomarkers to assist clinicians with diagnosis and treatment decisions for stroke, lung fibrosis, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brainomix Comparables
Compare Brainomix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RapidAI | 87% | |
| Nicolab | 85% | |
| Cercare Medical | 82% |
Brainomix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Feb 24, 2026 | ||||
| Series C | Mar 18, 2025 | ||||
| Series C Extension | Feb 24, 2024 | ||||
| Grant | Oct 12, 2023 | ||||
| Series B | Dec 16, 2021 | ||||
Series A | Apr 3, 2018 |
Key People
Founding team and executive leadership
Brainomix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Boehringer Ingelheim | Series C |
| IP Group | Series C |
| Hostplus Superannuation Fund | Series C Extension, Series C |
| IP Group Australia | Series C Extension |
| Boehringer Ingelheim Venture Fund | Series A, Series B, Series C |
| Modi Ventures | Series C Extension, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 30% MoM, reaching 10.8K.
- Apr 15, 2026
Monthly visitors increased 36% MoM to 11.5K.
Recent news
Latest coverage and updates
- attends_eventSep 8, 2026
Brainomix attended event European Respiratory Society (ERS) Conference on Sep 8th '26.
- partners_withSep 8, 2026
Brainomix partnered with Endeavor BioMedicines on Sep 8th '26.
- attends_eventAug 25, 2026
Brainomix attended event ERS Congress on Sep 5th '26.
Brainomix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Brainomix's valuation, stock price, and market status.
Is Brainomix a public or private company?
Brainomix is a private company.
What is the current stock price of Brainomix?
Brainomix is a private company with no public stock price. No recent secondary market data is available.
How much is Brainomix worth (valuation)?
Valuation information for Brainomix is not publicly available.
Can I buy Brainomix stock?
Brainomix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Brainomix's last funding round?
Brainomix's most recent funding round was Series C Extension on February 24, 2026.
Who are the main investors in Brainomix?
Key investors in Brainomix include Boehringer Ingelheim, Hostplus Superannuation Fund, Boehringer Ingelheim Venture Fund, Parkwalk Advisors.
Will Brainomix IPO soon?
No public IPO plans have been announced for Brainomix.
How can I track Brainomix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Brainomix's secondary market activity and sign up for updates.